CDTX insider buying and SEC filings, explained
Cidara Therapeutics, Inc. · CIK 1610618
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$339K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 31, 2017–Nov 10, 2020 | Purchase (code P) | Jeffrey Stein (CEO and Director) bought 4,262 shares indirectly (by trust) between Mar 31, 2017 and Nov 10, 2020 at about $79.55 ($339K), reported as a purchase (code P). Holdings by trust up 7% to 69,371 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 7, 2026 |
21 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CDTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.